This 2019 article from the Indian Journal of Surgical Oncology covers a very tiny group of patients undergoing HITHOC during an 8 1/2 year period has serious limitations (with a total of […]
A closer look at HITHOC in Germany
A look of HITHOC in two programs in Germany, Freiburg and Regensburg
HITHOC in 2018 – Where are we now?
We’ve come along way when discussing Mesothelioma and the use of hyperthermic intrathoracic chemotherapy (HITHOC) since this site was started back in 2010. In fact, for our first discussions about this technique, […]
Guest post: Dr. Migliore and the IV Mediterranean Symposium on Thoracic Oncology
Dr. Marcello Migliore reports on the highlights from the recent Mediterranean Symposium on Thoracic Oncology
The Mediterranean IV thoracic oncology symposium
It’s not too late to register for the upcoming Thoracic Oncology Symposium in Catania, Italy. The symposium is being held April 6th and 7th and is sponsored by the University of Catania and […]
Q and A with Migliore et al.. about Hithoc and Mesothelioma in Catania, Italy
Thoracics.org follows up with Dr. Marcello Migliore from the University of Catania, on his work in the area of HITHOC and malignant pleural mesothelioma
Mesothelioma, Hope and HITHOC
Is there hope? Thoracics.org discusses hope and mesothelioma along with the most recently published work in the area of cytoreductive surgery and intrathoracic chemotherapy (HITHOC).
